Lagarde Michelinsider trades
In SEC Form 4 filings, Lagarde Michel is listed as President and CEO of West Pharmaceutical Services Inc (WST). Lagarde Michel reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 10.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| WSTWest Pharmaceutical Services Inc | President and CEO | 6 | Sep 10 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 13,879 | $337.75 | $4,687,632 | 13,879 | No | Form 4 |
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 11,081 | $337.75 | $3,742,608 | 11,081 | No | Form 4 |
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 12,088 | $337.75 | $4,082,722 | 12,088 | No | Form 4 |
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 6,200 | $0.00 | $0 | 6,200 | No | Form 4 |
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 4,950 | $0.00 | $0 | 4,950 | No | Form 4 |
| WSTWest Pharmaceutical Services Inc | Sep 8 | Sep 10 | A · derivative | 3,600 | $0.00 | $0 | 3,600 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.